These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33711474)

  • 21. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.
    Mutlu Gençkal H; Erkisa M; Alper P; Sahin S; Ulukaya E; Ari F
    J Biol Inorg Chem; 2020 Feb; 25(1):161-177. PubMed ID: 31832781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity.
    Rajendiran V; Karthik R; Palaniandavar M; Stoeckli-Evans H; Periasamy VS; Akbarsha MA; Srinag BS; Krishnamurthy H
    Inorg Chem; 2007 Oct; 46(20):8208-21. PubMed ID: 17784750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.
    Savic M; Arsenijevic A; Milovanovic J; Stojanovic B; Stankovic V; Rilak Simovic A; Lazic D; Arsenijevic N; Milovanovic M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using methyl as substituted-radical in n-phen enhances the anticancer activities of [(DMF)Cu(n-phen)(NO3(-))2].
    Zhang B; Lu X; Wang G; Zhang W; Xia S; Chen Y
    J Inorg Biochem; 2014 Nov; 140():213-8. PubMed ID: 25168213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
    Anjomshoa M; Torkzadeh-Mahani M
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
    Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
    Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
    Borges LJH; Bull ÉS; Fernandes C; Horn A; Azeredo NF; Resende JALC; Freitas WR; Carvalho ECQ; Lemos LS; Jerdy H; Kanashiro MM
    Eur J Med Chem; 2016 Nov; 123():128-140. PubMed ID: 27474929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells.
    Ishida T; Kirchmeier MJ; Moase EH; Zalipsky S; Allen TM
    Biochim Biophys Acta; 2001 Dec; 1515(2):144-58. PubMed ID: 11718670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil.
    Azevedo A; Coelho MP; Pinho JO; Soares PIP; Reis CP; Borges JP; Gaspar MM
    Life Sci; 2024 May; 344():122558. PubMed ID: 38471621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes.
    Pellei M; Gandin V; Cimarelli C; Quaglia W; Mosca N; Bagnarelli L; Marzano C; Santini C
    J Inorg Biochem; 2018 Oct; 187():33-40. PubMed ID: 30053534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their Cytotoxicity.
    Nunes P; Correia I; Marques F; Matos AP; Dos Santos MMC; Azevedo CG; Capelo JL; Santos HM; Gama S; Pinheiro T; Cavaco I; Pessoa JC
    Inorg Chem; 2020 Jul; 59(13):9116-9134. PubMed ID: 32578983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
    Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
    Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Copper(I) complexes with phosphines P(p-OCH
    Komarnicka UK; Kozieł S; Zabierowski P; Kruszyński R; Lesiów MK; Tisato F; Porchia M; Kyzioł A
    J Inorg Biochem; 2020 Feb; 203():110926. PubMed ID: 31759264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes.
    Matos CP; Albino M; Lopes J; Viana AS; Côrte-Real L; Mendes F; Pessoa JC; Tomaz AI; Reis CP; Gaspar MM; Correia I
    Int J Pharm; 2022 Jul; 623():121925. PubMed ID: 35718249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.
    Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A
    Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Khorrami A
    Colloids Surf B Biointerfaces; 2014 Mar; 115():323-30. PubMed ID: 24394948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
    Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
    J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.
    Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
    Eur J Pharmacol; 2007 Aug; 569(1-2):16-28. PubMed ID: 17585902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.